YOU'RE INVITED!
San Francisco Bay Area
May 15-16, 2023
Hilton San Francisco Airport Bayfront
I'M SPEAKING
Charlotte Smith
Associate Professor in Management and Organisation, School of Business
University of Leicester
Responsible Business in the Psychedelics Industry; the Good, the Bad and the Ugly?
Join me on May 15-16, 2023, at the in San Francisco Bay Area
Following the success of the 2nd Annual Psychedelic Therapeutics and Drug Development Conference in 2022, we're thrilled to be hosting the 3rd Annual event on May 15-16, 2023 in the San Francisco Bay Area. This event has been organized to bring together the world’s leading researchers and leaders in academia, industry, the non-profit sector and government to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.
Our speakers and panelists will be covering important topics such as Clinical Trial Design, Intellectual Property, Regulatory Guidance, Psychedelic Drug Delivery, Commercialization, Legal Issues, Emerging Preclinical Science, and New Clinical Data among other topics. This event has been designed and curated for the benefit of key stakeholders in this burgeoning area and will provide practical guidance, discussion and networking.
Who Should Attend
Chief Executive Officers
Vice Presidents
Chief Medical Officers
Business Development Professionals
Regulatory Affairs Professionals
Research Scientists
R&D Professionals
Clinical Development Professionals
Licensing Professionals
Investigators
Medical Chemists
Chemists
Pharmacists
Scientists
Study Managers
Project Managers
Scientific Officers
Professors
Ph.D./Pharm.D. Students
Health Care Practitioners
Program Officers
Investors
Analysts
Medical Directors
Some Of The 2023 Featured Speakers
Joshua Woolley, MD, Ph.D.
Associate Professor, Psychiatry
UCSF Weill Institute for Neurosciences
Elliot Marseille, DrPH, MPP
UC Berkeley/UCSF Global Initiative for Psychedelic Science Economics
Health Strategies International
Jaspreet Grewal
Gul Dolen, MD, Ph.D
Associate Professor of Neuroscience, Brain Institute, Wendy Klag Center
Johns Hopkins University
CHAIR: Mark Johnston, MD,
Chief Executive Officer & Medical Director
Centricity Research
Gitte Knudsen, MD, DMSc
Reasons to Attend
I work for a CRO CNS clinical drug development and was enlightened to the extensive amount of psychedelic drug development that occurred before 2000 as well as to the breadth of science being done now. The heavy-hitters on the speaker list was impressive and made it clear this conference was a legitimate event. I will plan to attend next year in person. Also the technology for the speakers and the Q&A was excellent - best format I've seen for a large online meeting in the past year. Also being able to access the sessions after the conference through July is incredibly helpful. Thank you
